Goserelin

CHEBI:CHEBI_5523

Chemical Information

Molecular Formula
C59H84N18O14
Molecular Mass
1269.413
Charge
0
SMILES
C([C@H](NC([C@H](CC1=CNC=N1)NC(=O)[C@@H]2CCC(N2)=O)=O)C(N[C@H](C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H](C(N[C@H](C(N[C@H](C(=O)N4[C@H](C(NNC(N)=O)=O)CCC4)CCCNC(=N)N)=O)CC(C)C)=O)COC(C)(C)C)=O)=O)CO)=O)C=5C6=C(NC5)C=CC=C6
InChI
InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1
InChIKey
BLCLNMBMMGCOAS-URPVMXJPSA-N

Alternative Names

  • Decapeptide I
  • Goserelin
  • Goserelin acetate
  • zoladex

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
50610
oboInOwl#hasDbXref
KEGG:D00573
core#notation
CHEBI:5523

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
50610
oboInOwl#hasDbXref
KEGG:D00573
oboInOwl#id
CHEBI:5523
core#notation
CHEBI:5523
generic_name
goserelin
rxcui
105641
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
IMPLANT
marketing_start_date
20031125
route
SUBCUTANEOUS
active_ingredient_strength
10.8 mg/1
package_marketing_start_date
25-NOV-03
labeler_name
TerSera Therapeutics LLC
pharm_class
Gonadotropin Releasing Hormone Receptor Agonists [MoA]
manufacturer_name
TerSera Therapeutics LLC
product_ndc
70720-950
spl_id
71b8db45-e40e-4de5-bdab-c409c968c271
active_ingredient_name
GOSERELIN ACETATE
package_ndc
70720-950-36
package_description
1 POUCH in 1 CARTON (70720-950-36) / 1 SYRINGE in 1 POUCH / 1 IMPLANT in 1 SYRINGE
brand_name
ZOLADEX
brand_name_base
ZOLADEX
application_number
NDA019726
unii
6YUU2PV0U8
spl_set_id
294b168b-6e5f-4db9-bf70-d599271458b3
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#2_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_6468
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_104196
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect28734
owl#annotatedSource
t249042
owl#someValuesFrom
t564493